Resistant bacteria Explain what we should do to slow down the rate of Bacteria can evolve Explain how bacteria can development of resistant rapidly because become resistant to antibiotics. 4.6.3.1 strains of bacteria. they reproduce at a Explain how antibiotic 4.6.3.2 fast rate. Describe the impact of resistance has impacted on antibiotic resistance. 4.6.3.4 Mutations produce cleaning practices in Britain’s new strains. hospitals. Resistant strains Interpret data about antibiotic are not killed by resistance. antibiotics, so they Role play: life without survive and antibiotics. reproduce. Resistant strains Research MRSA and C. difficile spread because infections and treatment. people are not Discuss how the rate of immune and there development of resistant is no effective bacteria be slowed down. treatment. Discuss why there are few new MRSA is resistant antibiotics being developed, to antibiotics. and suggest how drug How to reduce the companies might be development of encouraged to develop some. resistant strains. Problems associated with the
4.6.3.1 4.6.3.2 4.6.3.4 Resistant bacteria Bacteria can evolve rapidly because they reproduce at a fast rate. Mutations produce new strains. Resistant strains are not killed by antibiotics, so they survive and reproduce. Resistant strains spread because people are not immune and there is no effective treatment. MRSA is resistant to antibiotics. How to reduce the development of resistant strains. Problems associated with the Explain what we should do to slow down the rate of development of resistant strains of bacteria. Describe the impact of antibiotic resistance. Explain how bacteria can become resistant to antibiotics. Explain how antibiotic resistance has impacted on cleaning practices in Britain’s hospitals. Interpret data about antibiotic resistance. Role play: life without antibiotics. Research MRSA and C. difficile infections and treatment. Discuss how the rate of development of resistant bacteria be slowed down. Discuss why there are few new antibiotics being developed, and suggest how drug companies might be encouraged to develop some.
AQA-8464-SOW-IVE.DOCX